Memantine is an Alzheimer’s disease drug that strongly impacts cognitive function by preferentially inhibiting GluN2C-containing and/or GluN2D-containing NMDARs (Kotermanski and Johnson, 2009; Kotermanski et al., 2009). This evidence concerns the gene GRIN2D and Alzheimer disease.